← All stocks

Envista Holdings Corp

NVST Scheduled selling only

CIK 0001757073 #1458 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$220.00K

$220.00K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$220.00K

$0.00 against sales at will

By person

16 insiders · 1 transaction

13.7×

Paul Keel holds 13.7 times base salary in stock. $15.16M of shares against $1.10M in salary for 2025.

Salary from the company's own proxy. The shares are what Paul Keel last reported holding, valued at $27.50, the price Common Stock was last bought or sold at on the open market here, on 20 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Reis Mischa

SVP, Strategy & Bus. Dev.

—

$220.00K (1) scheduled

−$220.00K

27,321

0.0170%

$751.33K

−36.0%

Keel Paul A

Chief Executive Officer

—

551,304

0.3432%

$15.16M

+36.9%

Hammes Eric D.

Chief Financial Officer

—

99,913

0.0622%

$2.75M

+12.6%

Huennekens R Scott

Director

—

82,105

0.0511%

$2.26M

+48.9%

Nance Mark E

General Counsel

—

81,252

0.0506%

$2.23M

+41.4%

Hulit Barbara B.

Director

—

79,820

0.0497%

$2.20M

+15.1%

Nilsson Stefan

President, Nobel Biocare

—

61,560

0.0383%

$1.69M

+35.4%

Carruthers Wendy

Director

—

59,940

0.0373%

$1.65M

+49.3%

TSINGOS CHRISTINE A

Director

—

59,930

0.0373%

$1.65M

+49.3%

Kaabi Faez C

Chief Accounting Officer

—

58,552

0.0365%

$1.61M

+31.2%

Raskas Daniel

Director

—

54,010

0.0336%

$1.49M

+57.8%

GALLAHUE KIERAN

Director

—

54,010

0.0336%

$1.49M

+57.8%

Jain Vivek

Director

—

52,945

0.0330%

$1.46M

+59.6%

Acurio Veronica

President, Orthodontics

—

48,806

0.0304%

$1.34M

+7.4%

Befidi Robert

President, Diagnostics

—

45,785

0.0285%

$1.26M

+15.1%

Pierce James Andrew

Director

—

18,485

0.0115%

$508.34K

—

Envista Holdings Corp

By person

Individual transactions

What was left out